| Financial Year |
March 31 2022 |
| Monetary Funds |
850,158,367.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,110,120.64 |
| Accounts Receivable |
1,094,042,492.21 |
| Advances to Suppliers |
85,888,462.03 |
| Other Receivables |
104,851,490.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
253,902,365.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,097,158.46 |
| Total Current Assets |
2,510,974,655.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
208,940,253.45 |
| Investment Properties |
137,995,211.82 |
| Fixed Assetes |
644,657,309.39 |
| Under-construction Projects |
145,610,030.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
204,588,150.73 |
| R&D expenses |
2,105,792.33 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
31,948,109.42 |
| Deferred Income Tax Assets |
59,445,739.24 |
| Other Non-Current Assets |
15,008,388.00 |
| Sub-Total of Non-Current Assets |
1,495,222,712.50 |
| Total Assets |
4,006,197,368.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
345,659,797.33 |
| Accounts Received In Advance |
1,809,188.60 |
| Employee Compensation Payable |
274,297,686.48 |
| Taxes Payable |
58,950,144.78 |
| Interest Payable |
-- |
| Dividend Payable |
200,000.00 |
| Other payables |
471,369,764.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,658,071.36 |
| Other Current Liabilities |
11,062,235.05 |
| Sub-Total of Current Liabilities |
1,311,045,745.87 |
| Long-term Loans |
25,259,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
183,457.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
174,320.00 |
| Deferred Income Tax Liabilities |
69,787,016.26 |
| Other Non-Current Liabilities |
66,875,916.75 |
| Sub-Total of Non-Current Liabilities |
199,666,522.93 |
| Total Liabilities |
1,510,712,268.80 |
| Paid-In Capital(Or Share Stock) |
380,192,370.00 |
| Capital Surplus |
1,062,400,375.37 |
| Surplus Reserve |
59,561,043.95 |
| LESS:Treasury Stock |
46,093,457.44 |
| Undistributed Profits |
1,019,705,407.53 |
| Minority Stockholder's Interest |
11,308,767.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,484,176,331.48 |
| Owner's Equity（Stockholder's Equity） |
2,495,485,099.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,006,197,368.13 |
